Heart Disease News and Research

Latest Heart Disease News and Research

FTC/TDF tablet reduces HIV infection among high-risk individuals: iPrEx study

In a finding with the potential to fundamentally change strategies to slow the global HIV epidemic, a new study called iPrEx shows that individuals at high risk for HIV infection who took a single daily tablet containing two widely used HIV medications, emtricitabine and tenofovir (FTC/TDF), experienced an average of 43.8% fewer HIV infections than those who received a placebo pill. New England Journal of Medicine, is the first evidence that this new HIV prevention method, called pre-exposure prophylaxis or PrEP, reduces HIV infection risk in people.

24 Nov 2010

Scott & White Healthcare’s Cardiac Rehabilitation Program receives AACVPR accreditation

The Cardiac Rehabilitation Program at Scott & White Healthcare in Temple has received accreditation from the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR).

24 Nov 2010

HOYA opens new Faculty Education and Experience Centre in Budapest

On Tuesday evening November 9th around 110 invitees witnessed the opening ceremony of HOYA's new Faculty Education and Experience Centre in the heart of Budapest.

24 Nov 2010

CIHI study finds impact of H1N1 pandemic on Canadian hospitals

While the H1N1 global pandemic may not have resulted in as many severe cases as originally predicted, a new study released today by the Canadian Institute for Health Information (CIHI) shows that more than 15,000 Canadians were admitted to hospital for H1N1 in Canada between April and December 2009.

24 Nov 2010

Bacterial study confirms TLR2 signaling vital for activating human airway epithelial cells

Researchers from the Boston University School of Medicine (BUSM) have demonstrated that commensal species of the genus Neisseriae are low inducers of human airway epithelial cell responses as compared to the pathogenic species.

24 Nov 2010

Software that simulates blood flow receives George Bell Prize for world's fastest supercomputing application

Researchers at New York University's Courant Institute of Mathematical Sciences have received the George Bell Prize, given to the world's fastest supercomputing application, for creating software that simulates blood flow. The award, which includes a cash prize of $10,000 and is given by the Association for Computing Machinery (ACM), is shared with researchers at Georgia Tech and Oak Ridge National Laboratory (ORNL).

24 Nov 2010

DFG announces establishment of eleven new Collaborative Research Centres

The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) will establish eleven new Collaborative Research Centres (CRC) as of 1 January 2011. This decision was made recently by the responsible Grants Committee at its autumn meeting in Bonn. The new CRCs will receive a total of - 94.4 million (including a 20 percent programme allowance for indirect project costs) for an initial funding period of four years.

24 Nov 2010

Centenary Institute launches new BD LSR-9 Flow Cytometer with nine lasers for studies of rare cells

A world-first research system to be launched today at the Centenary Institute will give medical researchers in Australia a new weapon in the fight against cancer and other life-threatening diseases. The new BD LSR-9 Flow Cytometer with its nine lasers will be the first user-operated flow cytometer with unprecedented ability to detect and analyse rare cells.

24 Nov 2010

Hepcidin hormone may be potential therapeutic tool for anemic blood disorders

A hormone made by the body may be a potential therapeutic tool for the treatment of two anemic blood disorders beta-thalassemia and hemochromatosis. The new research was led by scientists at Weill Cornell Medical College and published in the Journal of Clinical Investigation and the journal Blood.

24 Nov 2010

More salt in many holiday meals, cardiologist warns

There can be far more salt in many holiday meals than people realize, and the proof can be found at hospital emergency rooms. Heart problems aggravated or unmasked after ingestion of a significant amount of salt tend to make holidays such as Thanksgiving, Passover and Christmas very busy times for health providers like University of Medicine and Dentistry of New Jersey (UMDNJ) cardiologist Marc Klapholz, M.D., F.A.C.C.

24 Nov 2010

Experience of ill health associated with reduction or cessation of alcohol consumption

In a cross-sectional study from the 2004 and 2007 Australian National Drug Strategy Household (NDSH) surveys, respondents were questioned about their current and past drinking, the presence of formal diagnosis for specific diseases (heart disease, type 2 diabetes, hypertension, cancer, anxiety, depression) and self-perceived general health status. The sample sizes for the 2004 and 2007 NDSH surveys were 24,109 and 23,356, respectively.

24 Nov 2010

Less affluent cancer patients more likely to develop life-threatening health problems

CANCER patients from deprived backgrounds are more likely to develop life-threatening health problems, research published today (Wednesday) in the British Journal of Cancer shows.

24 Nov 2010

'Telehealth' devices allow patients to track illnesses from home

Thousands of seriously ill patients are relying on computerized health trackers to help keep them safe at home.

23 Nov 2010

FDA clears BG Medicine's Galectin-3 test to identify high risk patients with cardiovascular disease

BG Medicine, Inc., a U.S.-based life sciences company, announced today that the U.S. Food and Drug Administration has cleared the company's Galectin-3 test for use in conjunction with clinical evaluation as an aid to assess the prognosis of patients diagnosed with chronic heart failure. This marks the first time the FDA has cleared a test to measure galectin-3 blood levels, and is the first novel cardiac test cleared by the FDA in five years.

23 Nov 2010

Exercise combo best for type 2 diabetes: Study

A new study shows that a combination of aerobic exercise and resistance training may offer the biggest benefits for people with type 2 diabetes in helping them control their disease. This combination improved HbA1c levels much better than either form alone. HbA1c levels denote long term sugar or glycemic control in a diabetic patient. Normal HbA1c is 6% or less. People with diabetes are urged to keep their HbA1c below 7%.

23 Nov 2010

Budapest meeting to highlight discrepancies in using implantable devices among European countries

Even though the use of implantable devices for the treatment of heart failure and heart rhythm disturbances has increased enormously in Europe in recent years, there still remain large differences between countries. Indeed, a report last year in the European Journal of Heart Failure found that there is an underuse of devices in many of the European countries surveyed. This is especially so in the emerging economies of Eastern Europe.

23 Nov 2010

Innovative new roles and occupations in health sector of the future

Innovative new roles and occupations that could possibly emerge in the health sector of the future are explored in a new working paper published today by Skills for Health.

23 Nov 2010

Ergothioneine international congress 2011 to be held at UCLA

OXIS International, Inc., today announced that the "First International Congress on Ergothioneine, Anti-Oxidants, and Age Management Medicine" will be held Friday to Sunday, July 15-17, 2011, in the DeNeve Auditorium at the University of California, Los Angeles.

23 Nov 2010

Implanted devices to treat cardiac dysfunction show success in real world use

Implanted devices that treat cardiac dysfunction in heart failure patients are as successful in "real world" use as they are in controlled clinical trial settings, according to a large new study reported in Circulation: Journal of the American Heart Association.

23 Nov 2010

U.S mortality rate from congenital heart defects drops 24%: Report

The U.S. death rate from congenital heart defects dropped 24 percent from 1999 to 2006 among children and adults, according to research reported in Circulation: Journal of the American Heart Association.

23 Nov 2010

Heart Disease News and Research

Latest Heart Disease News and Research

FTC/TDF tablet reduces HIV infection among high-risk individuals: iPrEx study

Scott & White Healthcare’s Cardiac Rehabilitation Program receives AACVPR accreditation

HOYA opens new Faculty Education and Experience Centre in Budapest

CIHI study finds impact of H1N1 pandemic on Canadian hospitals

Bacterial study confirms TLR2 signaling vital for activating human airway epithelial cells

Software that simulates blood flow receives George Bell Prize for world's fastest supercomputing application

DFG announces establishment of eleven new Collaborative Research Centres

Centenary Institute launches new BD LSR-9 Flow Cytometer with nine lasers for studies of rare cells

Hepcidin hormone may be potential therapeutic tool for anemic blood disorders

More salt in many holiday meals, cardiologist warns

Experience of ill health associated with reduction or cessation of alcohol consumption

Less affluent cancer patients more likely to develop life-threatening health problems

'Telehealth' devices allow patients to track illnesses from home

FDA clears BG Medicine's Galectin-3 test to identify high risk patients with cardiovascular disease

Exercise combo best for type 2 diabetes: Study

Budapest meeting to highlight discrepancies in using implantable devices among European countries

Innovative new roles and occupations in health sector of the future

Ergothioneine international congress 2011 to be held at UCLA

Implanted devices to treat cardiac dysfunction show success in real world use

U.S mortality rate from congenital heart defects drops 24%: Report

Pharmaceutical Manufacturing - Industry Focus eBook eBook

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Heart Disease News and Research

Latest Heart Disease News and Research

Pharmaceutical Manufacturing - Industry Focus eBook eBook

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Newsletters you may be interested in